Literature DB >> 3258617

Regulation of colony-stimulating factor 1-dependent macrophage precursor proliferation by type beta transforming growth factor.

G Strassmann1, M D Cole, W Newman.   

Abstract

Transforming growth factor (TGF) type beta, a potent growth modulator, has recently been shown to inhibit the proliferation and function of several types of immune cells. This report investigates the effect of human platelet purified TGF-beta on CSF-1-induced proliferation in liquid cultures. We used two cell types to study TGF-beta effects, bone marrow precursors and a c-myc partially transformed CSF-1-dependent macrophage cell line designated BMM-8. We found that CSF-1-dependent proliferation of both cell types was strongly inhibited by TGF-beta in a dose-dependent manner. Approximately 1.6 and 8 pM TGF-beta inhibited 50% of CSF-1 proliferation of the bone marrow precursors and BMM-8, respectively. Inhibition appeared to be reversible, as bone marrow and BMM-8 cells proliferated in response to CSF-1 after preincubation of the cells in TGF-beta. Interestingly, inhibition of hematopoietic cells was observed only after a lag period of 24 to 48 h after onset of cultures. TGF-beta inhibition was partially diminished when increasing amounts of CSF-1 were added to the cultures. TGF-beta inhibition did not involve secondary inhibitory factors such as IFN or PG, both of which have been previously shown to suppress CSF responsiveness. Finally, flow cytometric analysis of the cell cycle indicated that within 48 h, TGF-beta-treated BMM-8 cells were prevented from entering S phase. These results suggest that TGF-beta may play an important role in the negative regulation of macrophage production.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258617

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  The role of transforming growth factor-beta in inflammatory processes.

Authors:  S M Wahl
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 2.  Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s.

Authors:  E D Harris
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

3.  Delayed neonatal lung macrophage differentiation in a mouse model of in utero ethanol exposure.

Authors:  Theresa W Gauthier; Xiao-Du Ping; Levan Gabelaia; Lou Ann S Brown
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-09       Impact factor: 5.464

4.  Transforming growth factor-beta 1 inhibits activation of macrophage cell line RAW 264.7 for cell killing.

Authors:  M Haak-Frendscho; T A Wynn; C J Czuprynski; D Paulnock
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

5.  The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors.

Authors:  Masahiro Masuya; Naoyuki Katayama; Natsuki Hoshino; Hiroyoshi Nishikawa; Seiji Sakano; Hiroto Araki; Hidetsugu Mitani; Hirohito Suzuki; Hiroyuki Miyashita; Kyoko Kobayashi; Kazuhiro Nishii; Nobuyuki Minami; Hiroshi Shiku
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

6.  The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site.

Authors:  Y D Yoo; C J Chiou; K S Choi; Y Yi; S Michelson; S Kim; G S Hayward; S J Kim
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

Review 7.  Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.

Authors:  S M Wahl
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

8.  Normal mouse lung tissue produces a growth-inhibitory factor(s) preferential for mouse monocytic leukemia cells.

Authors:  T Ikuta; Y Honma; J Okabe-Kado; T Kasukabe; M Hozumi
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals.

Authors:  M E Brandes; J B Allen; Y Ogawa; S M Wahl
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

10.  bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapy.

Authors:  S Kondo; D Yin; J Takeuchi; T Morimura; Y Oda; H Kikuchi
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.